Tenofovir AF

Janessa M. Smith, PharmD, BCPS
Tenofovir AF is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

Treatment of HIV-1 infection as part of a single-tablet regimen (STR), Genvoya or Odefsey, or NRTI combination tablet Descovy, for adults and pediatric patients 12 years of age and older who are treatment naive or to replace the current antiretroviral regimen in those who are virologically suppressed

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

Treatment of HIV-1 infection as part of a single-tablet regimen (STR), Genvoya or Odefsey, or NRTI combination tablet Descovy, for adults and pediatric patients 12 years of age and older who are treatment naive or to replace the current antiretroviral regimen in those who are virologically suppressed

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: November 8, 2016